Arsenic Trioxide Promotes Tumor Progression by Inducing the Formation of PGCCs and Embryonic Hemoglobin in Colon Cancer Cells
Arsenic trioxide (ATO) has been used to treat acute promyelocytic leukemia. However, it is not effective in treating solid tumors such as colorectal cancer. We have previously reported that polyploid giant cancer cells (PGCCs) exhibiting the characteristics of cancer stem cells can be generated by v...
Main Authors: | Zugui Li, Minying Zheng, Hao Zhang, Xiaohui Yang, Linlin Fan, Fangmei Fu, Junjie Fu, Rui Niu, Man Yan, Shiwu Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.720814/full |
Similar Items
-
High Migration and Invasion Ability of PGCCs and Their Daughter Cells Associated With the Nuclear Localization of S100A10 Modified by SUMOylation
by: Qi Zhao, et al.
Published: (2021-07-01) -
Different p53 genotypes regulating different phosphorylation sites and subcellular location of CDC25C associated with the formation of polyploid giant cancer cells
by: Kai Liu, et al.
Published: (2020-05-01) -
Molecular Mechanisms by Which S100A4 Regulates the Migration and Invasion of PGCCs With Their Daughter Cells in Human Colorectal Cancer
by: Fei Fei, et al.
Published: (2020-02-01) -
Treatment of new cases of Acute Promyelocytic Leukemia With Arsenic Trioxide
by: Ardeshir Ghavamzadeh, et al.
Published: (2005-03-01) -
Establishment and characterization of arsenic trioxide resistant KB/ATO cells
by: Yun-Kai Zhang, et al.
Published: (2017-09-01)